As the RNA solutions leader for academic research and therapeutic development, Eclipsebio is dedicated to sponsoring events that bring together world experts in RNA biology and therapeutics. Eclipsebio is proud to announce our sponsorship of the Mechanisms of RNA Decay meeting. The meeting will be held in Lisbon, from August 18 to August 22. This conference will feature discussions on:
- Methods for studying RNA decay
- The process of RNA decay across organisms
- Aspects of RNA decay mechanisms, including the relationship between degradation and translation
We are looking forward to supporting the exciting exchange of ideas and career development opportunities that this meeting offers.
If you are interested in making your own discoveries with our comprehensive solutions for therapeutic development or academic research, contact our team of RNA experts today.
Latest news
2026 Data Catalyst Award Call for Applications
The Data Catalyst Award helps offset the cost of RNA profiling experiments using Eclipsebio's assays from our RNA profiling portfolio and contributes to the eVERSE database.
Eclipsebio Launches eCOMPASS™, an AI-Enabled Lab-in-the-Loop Platform for RNA Therapeutic Development
Eclipsebio's eCOMPASS platform combines AI-optimized design and sequencing-based analytics to produce successful RNA therapeutics efficiently.
2026 mRNA Innovators Award Call for Applications
The mRNA Innovators Award offers matching funds to design and validate a therapeutic of interest using Eclipsebio's design models and characterization methods.
Eclipsebio Acquires Terrain Bio to Expand Its End-to-End AI Platform for the Design, Manufacturing, and Validation of RNA Therapeutics
Originally posted on Business Wire SAN DIEGO, January 26, 2026 — Eclipse Bioinnovations, Inc. (Eclipsebio), the leader in sequencing-based analytics for RNA therapeutics, today announced the acquisition of Terrain Bio, a techbio company specializing in AI/ML RNA design and manufacturing analytics. The acquisition accelerates Eclipsebio’s strategy to deliver an integrated, data-first platform to support RNA […]